ELFN1 and early-onset autosomal dominant Alzheimer disease: Elfn1 protein has been shown to play a role in the modulation of synaptic transmission through its trans interaction with the metabotropic glutamate receptors69, which serve as therapeutic targets for several neurological diseases, including Alzheimer’s disease, epilepsy, and Parkinson’s disease70–72.